Skip to main content

Advertisement

SpringerLink
Log in

Preoperative plasma fibrinogen is associated with poor prognosis in esophageal carcinoma: a meta-analysis

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this meta-analysis was to investigate preoperative plasma fibrinogen (PPF) as a prognostic marker in esophageal carcinoma (EC) by meta-analysis.

Methods

Relevant studies were sought in the databases including Pubmed, Web of Science, Cochrane library, and Wanfang databases up to Oct 10th, 2017. Hazard ratios (HRs) with corresponding 95% confidence intervals (CIs) were used as effective value, and pooled HRs were synthesized by STATA 14.0 to assess the prognostic impact of PPF on EC patients.

Results

A total of 8 studies with 2827 patients were collected in this meta-analysis. Our results revealed that high PPF was significantly associated with poor OS (HR = 1.90, 95% CI 1.56–2.33, P = 0.000; HR = 1.76, 95% CI 1.28–2.42, P = 0.000) and poor DFS (HR = 1.91, 95% CI 1.50–2.43, P = 0.000; HR = 1.51, 95% CI 1.16–1.97, P = 0.000) in EC patients from univariate and multivariate analysis results, respectively, which suggested that EC patients with high PPF will suffer from high postoperative mortality and recurrence rate.

Conclusion

High PPF was significantly associated with poor OS and DFS in EC patients. Fibrinogen can serve as a prognostic marker and even a future targeting molecule during the treatment of EC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.

    Article  PubMed Central  Google Scholar 

  2. Lordick F. Treatment of oesophageal cancer—stressing the patient perspective. Eur J Cancer. 2017;84:360–2. https://doi.org/10.1016/j.ejca.2017.08.021.

    Article  PubMed  Google Scholar 

  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.

    Article  PubMed  Google Scholar 

  4. Otten HM, Prins MH. Venous thromboembolism and occult malignancy. Thromb Res. 2001;102(6):V187–94.

    Article  PubMed  CAS  Google Scholar 

  5. Kołodziejczyk J, Ponczek MB. The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemp Oncol (Pozn). 2013;17(2):113–9.

    PubMed  PubMed Central  Google Scholar 

  6. Falanga A, Russo L, Milesi V, Vignoli A. Mechanisms and risk factors of thrombosis in cancer. Crit Rev Oncol Hematol. 2017;118:79–83.

    Article  PubMed  Google Scholar 

  7. Ebrahimi S, Rahmani F, Behnam-Rassouli R, Hoseinkhani F, Parizadeh MR, Keramati MR, et al. Proinflammatory signaling functions of thrombin in cancer. J Cell Physiol. 2017;232(9):2323–9.

    Article  PubMed  CAS  Google Scholar 

  8. Blombäck B, Blombäck M. The molecular structure of fibrinogen. Ann NY Acad Sci. 1972;8(202):77–97.

    Article  Google Scholar 

  9. Pulanić D, Rudan I. The past decade: fibrinogen. Coll Antropol. 2005;29(1):341–9.

    PubMed  Google Scholar 

  10. Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012;34(1):43–62.

    Article  PubMed  CAS  Google Scholar 

  11. Falanga A, Panova-Noeva M, Russo L. Procoagulant mechanisms in tumour cells. Best Pract Res Clin Haematol. 2009;22(1):49–60.

    Article  PubMed  CAS  Google Scholar 

  12. Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann NY Acad Sci. 2001;936:406–25.

    Article  PubMed  CAS  Google Scholar 

  13. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–45.

    Article  PubMed  CAS  Google Scholar 

  14. Sampson MT, Kakkar AK. Coagulation proteases and human cancer. Biochem Soc Trans. 2002;30(2):201–7.

    Article  PubMed  CAS  Google Scholar 

  15. Perisanidis C, Psyrri A, Cohen EE, Engelmann J, Heinze G, Perisanidis B, et al. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):960–70.

    Article  PubMed  CAS  Google Scholar 

  16. Ilhan-Mutlu A, Starlinger P, Perkmann T, Schoppmann SF, Preusser M, Birner P. Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer. Biomark Med. 2015;9(4):327–35.

    Article  PubMed  CAS  Google Scholar 

  17. Wang J, Liu H, Shao N, Tan B, Song Q, Jia Y, et al. The clinical significance of preoperative plasma fibrinogen level and platelet count in resectable esophageal squamous cell carcinoma. World J Surg Oncol. 2015;22(13):157. https://doi.org/10.1186/s12957-015-0543-4.

    Article  Google Scholar 

  18. Matsuda S, Takeuchi H, Fukuda K, Nakamura R, Takahashi T, Wada N, et al. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment. Dis Esophagus. 2014;27(7):654–61.

    Article  PubMed  CAS  Google Scholar 

  19. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323(7306):224–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Stang A. Critical evaluation of the Newcastle–Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.

    Article  PubMed  Google Scholar 

  21. Sun XD, Shi XJ, Chen YG, Wang CL, Ma Q, Lv GY. Elevated preoperative neutrophil–lymphocyte ratio is associated with poor prognosis in hepatocellular carcinoma patients treated with liver transplantation: a meta-analysis. Gastroenterol Res Pract. 2016;2016:4743808. https://doi.org/10.1155/2016/4743808 (Epub 2015 Dec 30).

    Article  PubMed  Google Scholar 

  22. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.

    Article  PubMed  Google Scholar 

  23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.

    Article  PubMed  CAS  Google Scholar 

  25. Zhang F, Wang Y, Sun P, Wang ZQ, Wang DS, Zhang DS, et al. Fibrinogen promotes malignant biological tumor behavior involving epithelial–mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2017;. https://doi.org/10.1007/s00432-017-2493-4.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Wakatsuki K, Matsumoto S, Migita K, Ito M, Kunishige T, Nakade H, et al. Preoperative plasma fibrinogen is associated with lymph node metastasis and predicts prognosis in resectable esophageal cancer. World J Surg. 2017;41(8):2068–77.

    Article  PubMed  Google Scholar 

  27. Zhang SS, Lei YY, Cai XL, Yang H, Xia X, Luo KJ, et al. Preoperative serum fibrinogen is an independent prognostic factor in operable esophageal cancer. Oncotarget. 2016;7(18):25461–9.

    PubMed  PubMed Central  Google Scholar 

  28. Qiao CR, Zhao S, Li XN, Zhao J, Zhu DY, Wu K, et al. The prognostic and clinicopahtological role of peripheral plasma fibrinogen and platelete in esophageal squamous cell carcinoma. Chin J of Gerontol. 2016;1(36):348–50 (Article in Chinese).

    Google Scholar 

  29. Zhang D, Zhou X, Bao W, Chen Y, Cheng L, Qiu G, et al. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma. Oncotarget. 2015;6(35):38410–20.

    PubMed  PubMed Central  Google Scholar 

  30. Arigami T, Okumura H, Matsumoto M, Uchikado Y, Uenosono Y, Kita Y, et al. Analysis of the fibrinogen and neutrophil-lymphocyte ratio in esophageal squamous cell carcinoma: a promising blood marker of tumor progression and prognosis. Medicine (Baltimore). 2015;94(42):e1702.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Takeuchi H, Ikeuchi S, Kitagawa Y, Shimada A, Oishi T, Isobe Y, et al. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroenterol Hepatol. 2007;22(12):2222–7.

    Article  PubMed  CAS  Google Scholar 

  32. Kijima T, Arigami T, Uchikado Y, Uenosono Y, Kita Y, Owaki T, et al. Combined fibrinogen and neutrophil–lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma. Cancer Sci. 2017;108(2):193–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Suzuki T, Shimada H, Nanami T, Oshima Y, Yajima S, Washizawa N, et al. Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma. Int J Clin Oncol. 2017;22(3):461–8.

    Article  PubMed  CAS  Google Scholar 

  34. Tan Z, Zhang M, Han Q, Wen J, Luo K, Lin P, et al. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the fibrinogen/albumin ratio. J Cancer. 2017;8(6):1025–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Li XH, Wang XP, Gu WS, Lin JH, Huang H, Kang T, et al. Clinical significance of preoperative thrombin time in patients with esophageal squamous cell carcinoma following surgical resection. PLoS ONE. 2015;10(10):e0140323.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Wayman J, O’Hanlon D, Hayes N, Shaw I, Griffin SM. Fibrinogen levels correlate with stage of disease in patients with oesophageal cancer. Br J Surg. 1997;84(2):185–8.

    Article  PubMed  CAS  Google Scholar 

  37. Zhao C, Su Y, Zhang J, Feng Q, Qu L, Wang L, et al. Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis. Cancer Sci. 2015;106(11):1596–606.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 2000;96(10):3302–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. G. Y. Lv and Y. Yu contributed equally to this work.

Authors and Affiliations

  1. Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, 130021, Jilin province, China

    G. Y. Lv, Y. Yu, X. D. Sun & D. W. Sun

  2. Department of Dermatology, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China

    L. An

Authors
  1. G. Y. Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. An
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X. D. Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. W. Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. W. Sun.

Ethics declarations

Conflict of interests

All the authors declare there is no conflict of interest in this research.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lv, G.Y., Yu, Y., An, L. et al. Preoperative plasma fibrinogen is associated with poor prognosis in esophageal carcinoma: a meta-analysis. Clin Transl Oncol 20, 853–861 (2018). https://doi.org/10.1007/s12094-017-1794-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-017-1794-z

Keywords

Search

Navigation